United States Neurology Devices Market Outlook to 2023 - CSF Management, Interventional Neurology, Neurostimulation Devices, Neurosurgical Products, Radiosurgery and Neurological Diagnostic Equipment

2017-07-10
Price :
Published : Jul-2017
No. of Pages : 532
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Neurology Devices Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 10
3 Neurology Devices Market, United States 14
3.1 Neurology Devices Market, United States, Revenue ($m), 2009-2023 14
3.2 Neurology Devices Market, United States, Revenue Mix ($m), 2016 16
3.3 Neurology Devices Market, United States, Category Contribution by Revenue ($m), 2016 17
3.4 Neurology Devices Market, United States, Revenue ($m), 2009-2016 18
3.5 Neurology Devices Market, United States, Revenue ($m), 2016-2023 20
3.6 Neurology Devices Market, United States, Volume (Units), 2009-2023 22
3.7 Neurology Devices Market, United States, Volume (Units), 2009-2016 24
3.8 Neurology Devices Market, United States, Volume (Units), 2016-2023 26
3.9 Neurology Devices Market, United States, Company Share by Revenue ($m), 2016 28
4 CSF Management Market, United States 30
4.1 CSF Management Market, United States, Revenue Mix ($m), 2016 30
4.2 CSF Management Market, United States, Segment Contribution (%), 2016 31
4.3 CSF Management Market, United States, Revenue ($m), 2009-2016 32
4.4 CSF Management Market, United States, Revenue ($m), 2016-2023 34
4.5 CSF Management Market, United States, Volume (Units), 2009-2016 36
4.6 CSF Management Market, United States, Volume (Units), 2016-2023 38
4.7 CSF Management Market, United States, Distribution Share by Revenue ($m), 2015-2016 40
4.8 CSF Management Market, United States, Company Share by Revenue ($m), 2016 41
5 Interventional Neurology Market, United States 42
5.1 Interventional Neurology Market, United States, Revenue Mix ($m), 2016 42
5.2 Interventional Neurology Market, United States, Segment Contribution (%), 2016 43
5.3 Interventional Neurology Market, United States, Revenue ($m), 2009-2016 44
5.4 Interventional Neurology Market, United States, Revenue ($m), 2016-2023 46
5.5 Interventional Neurology Market, United States, Volume (Units), 2009-2016 56
5.6 Interventional Neurology Market, United States, Volume (Units), 2016-2023 58
5.7 Interventional Neurology Market, United States, Distribution Share by Revenue ($m), 2015-2016 68
5.8 Interventional Neurology Market, United States, Company Share by Revenue ($m), 2016 69
6 Neurological Diagnostic Equipment Market, United States 71
6.1 Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2016 71
6.2 Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2016 72
6.3 Neurological Diagnostic Equipment Market, United States, Revenue ($m), 2009-2016 73
6.4 Neurological Diagnostic Equipment Market, United States, Revenue ($m), 2016-2023 75
6.5 Neurological Diagnostic Equipment Market, United States, Volume (Units), 2009-2016 77
6.6 Neurological Diagnostic Equipment Market, United States, Volume (Units), 2016-2023 79
6.7 Neurological Diagnostic Equipment Market, United States, Distribution Share by Revenue ($m), 2015-2016 81
6.8 Neurological Diagnostic Equipment Market, United States, Company Share by Revenue ($m), 2016 82
7 Neurostimulation Devices Market, United States 84
7.1 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2016 84
7.2 Neurostimulation Devices Market, United States, Segment Contribution (%), 2016 85
7.3 Neurostimulation Devices Market, United States, Revenue ($m), 2009-2016 86
7.4 Neurostimulation Devices Market, United States, Revenue ($m), 2016-2023 88
7.5 Neurostimulation Devices Market, United States, Volume (Units), 2009-2016 90
7.6 Neurostimulation Devices Market, United States, Volume (Units), 2016-2023 92
7.7 Neurostimulation Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016 94
7.8 Neurostimulation Devices Market, United States, Company Share by Revenue ($m), 2016 95
8 Neurosurgical Products Market, United States 97
8.1 Neurosurgical Products Market, United States, Revenue Mix ($m), 2016 97
8.2 Neurosurgical Products Market, United States, Segment Contribution (%), 2016 98
8.3 Neurosurgical Products Market, United States, Revenue ($m), 2009-2016 99
8.4 Neurosurgical Products Market, United States, Revenue ($m), 2016-2023 101
8.5 Neurosurgical Products Market, United States, Volume (Units), 2009-2016 103
8.6 Neurosurgical Products Market, United States, Volume (Units), 2016-2023 105
8.7 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2015-2016 107
8.8 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2016 108
9 Radiosurgery Market, United States 110
9.1 Radiosurgery Market, United States, Revenue Mix ($m), 2016 110
9.2 Radiosurgery Market, United States, Segment Contribution (%), 2016 111
9.3 Radiosurgery Market, United States, Revenue ($m), 2009-2016 112
9.4 Radiosurgery Market, United States, Revenue ($m), 2016-2023 114
9.5 Radiosurgery Market, United States, Volume (Units), 2009-2016 116
9.6 Radiosurgery Market, United States, Volume (Units), 2016-2023 118
9.7 Radiosurgery Market, United States, Distribution Share by Revenue ($m), 2016 120
9.8 Radiosurgery Market, United States, Company Share by Revenue ($m), 2016 121
10 Overview of Key Companies in United States, Neurology Devices Market 122
10.1 Medtronic Plc 122
10.2 Elekta AB 122
10.3 DePuy Synthes Inc 122
10.4 B. Braun Melsungen AG 123
10.5 Integra LifeSciences Holdings Corp 123
10.6 Stryker Corporation 123
10.7 Natus Medical Incorporated 123
10.8 Boston Scientific Corp 124
10.9 St. Jude Medical LLC 124
10.10 LivaNova PLC 124
10.11 Nihon Kohden Corp 124
10.12 Terumo Corp 125
11 Neurology Devices Market Pipeline Products 126
12 Financial Deals Landscape 130
12.1 Acquisition 130
12.2 Asset Transactions 144
12.3 Debt Offerings 147
12.4 Equity Offerings 150
12.5 Partnerships 170
12.6 Venture Financing 181
13 Recent Developments 210
13.1 Corporate Communications 210
13.2 Financial Announcements 266
13.3 Government and Public Interest 444
13.4 Legal And Regulatory 451
13.5 Other Significant Developments 459
13.6 Product News 486
13.7 Strategy And Business Planning 508
14 Appendix 516
14.1 Research Methodology 517
14.2 GlobalData Consulting 519
14.3 Contact Us 520
14.4 Disclaimer 520

1.1 List of Tables
Table 1: Neurology Devices Market, United States, Revenue ($m), USD Constant, 2009-2023 27
Table 2: Neurology Devices Market, United States, Category Contribution by Revenue ($m), 2016 29
Table 3: Neurology Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 4: Neurology Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 5: Neurology Devices Market, United States, Volume (Units), 2009-2023 35
Table 6: Neurology Devices Market, United States, Volume (Units), Historic, 2009-2016 37
Table 7: Neurology Devices Market, United States, Volume (Units), Forecast, 2016-2023 39
Table 8: Neurology Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 41
Table 9: CSF Management Market, United States, Segment Contribution (%), 2016 43
Table 10: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 45
Table 11: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 47
Table 12: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 49
Table 13: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 51
Table 14: CSF Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 52
Table 15: CSF Management Market, United States, Company Share by Revenue ($m), USD Constant, 2016 53
Table 16: Interventional Neurology Market, United States, Segment Contribution (%), 2016 55
Table 17: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 57
Table 18: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 59
Table 19: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 61
Table 20: Navigational System Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 63
Table 21: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 65
Table 22: Navigational System Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 67
Table 23: Interventional Neurology Market, United States, Volume (Units), Historic, 2009-2016 69
Table 24: Interventional Neurology Market, United States, Volume (Units), Forecast, 2016-2023 71
Table 25: Embolization and Coiling Devices Market, United States, Volume (Units), Historic, 2009-2016 73
Table 26: Navigational System Market, United States, Volume (Units), Historic, 2009-2016 75
Table 27: Embolization and Coiling Devices Market, United States, Volume (Units), Forecast, 2016-2023 77
Table 28: Navigational System Market, United States, Volume (Units), Forecast, 2016-2023 79
Table 29: Interventional Neurology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 80
Table 30: Interventional Neurology Market, United States, Company Share by Revenue ($m), USD Constant, 2016 82
Table 31: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2016 84
Table 32: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 86
Table 33: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 88
Table 34: Neurological Diagnostic Equipment Market, United States, Volume (Units), Historic, 2009-2016 90
Table 35: Neurological Diagnostic Equipment Market, United States, Volume (Units), Forecast, 2016-2023 92
Table 36: Neurological Diagnostic Equipment Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 93
Table 37: Neurological Diagnostic Equipment Market, United States, Company Share by Revenue ($m), USD Constant, 2016 95
Table 38: Neurostimulation Devices Market, United States, Segment Contribution (%), 2016 97
Table 39: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 99
Table 40: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 101
Table 41: Neurostimulation Devices Market, United States, Volume (Units), Historic, 2009-2016 103
Table 42: Neurostimulation Devices Market, United States, Volume (Units), Forecast, 2016-2023 105
Table 43: Neurostimulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 106
Table 44: Neurostimulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 108
Table 45: Neurosurgical Products Market, United States, Segment Contribution (%), 2016 110
Table 46: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 112
Table 47: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 114
Table 48: Neurosurgical Products Market, United States, Volume (Units), Historic, 2009-2016 116
Table 49: Neurosurgical Products Market, United States, Volume (Units), Forecast, 2016-2023 118
Table 50: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016 119
Table 51: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2016 121
Table 52: Radiosurgery Market, United States, Segment Contribution (%), 2016 123
Table 53: Radiosurgery Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 125
Table 54: Radiosurgery Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 127
Table 55: Radiosurgery Market, United States, Volume (Units), Historic, 2009-2016 129
Table 56: Radiosurgery Market, United States, Volume (Units), Forecast, 2016-2023 131
Table 57: Radiosurgery Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 132
Table 58: Radiosurgery Market, United States, Company Share by Revenue ($m), USD Constant, 2016 133
Table 59: Neurology Devices Market Pipeline Products 138
Table 60: DePuy Synthes Acquires Sentio 142
Table 61: Koninklijke Philips to Acquire Electrical Geodesics for USD36.7 Million 143
Table 62: TE Connectivity Acquires MicroGroup 145
Table 63: Becton, Dickinson to Acquire C. R. Bard for USD24 Billion 146
Table 64: PixarBio Terminates Acquisition of InVivo Therapeutics for USD77 Million 148
Table 65: Codman Neuro Acquires Pulsar Vascular 149
Table 66: Teleflex Acquires Vascular Solutions for up to USD1 Billion 150
Table 67: SpecialtyCare Acquires Sentient Medical Systems 152
Table 68: BALT International Acquires Blockade Medical 153
Table 69: Boston Scientific Acquires Cosman Medical 154
Table 70: Endonovo Therapeutics to Acquire Rio Grande Neurosciences for USD30 Million 155
Table 71: Integra LifeSciences Plans to Acquire Neurosurgery Business of Codman Neuro for USD1 Billion 156
Table 72: BrainCool Acquires Assets of Benechill for USD2.2 Million 158
Table 73: MIVI Neuroscience secures $0.85 million in debt offering 159
Table 74: Stryker Prices Public Offering of 1.800% Notes Due 2019 for USD500 Million 160
Table 75: Microbot Medical Raises USD10 Million in Private Placement of Shares 162
Table 76: MRI Interventions Raises USD13.3 Million in Private Placement of Units 163
Table 77: Cara Therapeutics Raises USD92 Million in Public Offering of Shares 164
Table 78: Penumbra Raises USD113.6 Million in Underwritten Public Offering of Shares 166
Table 79: InspireMD Prices Public Offering of Shares and Warrants for USD7.5 Million 168
Table 80: Helius Medical Technologies Raises USD9.5 Million in Public Offering of Shares 169
Table 81: Capnia Raises USD2 Million in First Tranche of Private Placement of Shares 171
Table 82: Braeburn Pharma to Raise USD40 Million in Private Placement of Shares 173
Table 83: Capnia Raises USD10 Million in Private Placement of Shares 174
Table 84: Zynex to Raise USD1.5 Million in Private Placement 175
Table 85: Myomo Files for Initial Public Offering of Common Shares 176
Table 86: Transgenomic to Raise up to USD7 Million in Private Placement of Shares 177
Table 87: AxoGen Raises USD20 Million in Public Offering of Shares 179
Table 88: MRI Interventions to Raise USD4.3 Million in Private Placement of Units 181
Table 89: Colorado State University and Synaptive Medical Enter into Partnership 182
Table 90: Mevion Medical Enters into Agreement with medPhoton 183
Table 91: MRI Interventions Enters into Co-Development Agreement with Mayo Clinic 184
Table 92: Microbot Medical Enters into Research Agreement with Washington University School of Medicine 185
Table 93: CytoSen Therapeutics Enters Into Licensing Agreement with University of Central Florida 187
Table 94: Juno Biomedical Enters into Partnership with Promenade Software 188
Table 95: Thorlabs Enters into Licensing Agreement with Howard Hughes Medical Institute 189
Table 96: Cerevast Medical Enters into Licensing Agreement with Arizona State University 190
Table 97: Quanterix Enters into Licensing Agreement with Banyan Biomarkers 191
Table 98: Euroimmun Enters into Licensing Agreement with Iron Horse Diagnostics 192
Table 99: Mindstrong Health Raises USD14 Million in Series A Financing 193
Table 100: Neuronetics Raises USD15 Million in Series G Round of Financing 194
Table 101: Monteris Medical Raises USD26.6 Million in Series C Financing 196
Table 102: InNeuroCo Raises USD0.8 Million in Venture Funding 197
Table 103: BrainCheck Raises Additional USD1.5 Million in Seed Financing 198
Table 104: Acera Surgical Raises USD0.6 Million in Venture Financing 199
Table 105: Transverse Medical to Raise USD3 Million in Venture Financing 200
Table 106: Axonics Modulation Technologies Raises USD14.5 Million in Series C Financing 201
Table 107: Synchron Raises USD10 Million in Series A Financing 203
Table 108: Neural Analytics Raises USD10.2 Million in Venture Financing 204
Table 109: Dynatronics Raises USD7.8 Million in Venture Financing 205
Table 110: SetPoint Medical Raises Funds through Venture Financing 206
Table 111: NeuroOne Raises USD1.2 Million in Seed Financing 208
Table 112: Cereve Raises USD38 Million in Series B Financing 209
Table 113: Neurable Raises USD2 Million in Seed Financing 210
Table 114: NeuroVasc Technologies Raises USD1 Million in Venture Financing 211
Table 115: ReliefBand Technologies to Raise USD8 Million in Venture Financing 212
Table 116: NeuroRecovery Tech Raises USD3 Million in Venture Financing 213
Table 117: Checkpoint Surgical Raises USD0.5 Million in Venture Financing 214
Table 118: Monteris Medical Raises USD6.8 Million in Venture Financing 215
Table 119: Neuro Kinetics Raises Additional USD1.8 Million in Venture Financing 216
Table 120: AbiliLife Secures Venture Funding from Innovation Works 217
Table 121: Liberate Medical Raises Additional USD0.25 Million in Venture Financing 218
Table 122: Liberate Medical Raises USD0.4 Million in Venture Financing 219
Table 123: Potrero Medical Raises USD4.8 Million in Financing 220
Table 124: AbiliLife Raises Funds through Venture Financing 221

1.2 List of Figures
Figure 1: Neurology Devices Market, United States, Revenue ($m), USD Constant, 2009-2023 26
Figure 2: Neurology Devices Market, United States, Revenue Mix ($m), 2016 28
Figure 3: Neurology Devices Market, United States, Category Contribution (%), 2016 29
Figure 4: Neurology Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 5: Neurology Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 6: Neurology Devices Market, United States, Volume (Units), 2009-2023 34
Figure 7: Neurology Devices Market, United States, Volume (Units), Historic, 2009-2016 36
Figure 8: Neurology Devices Market, United States, Volume (Units), Forecast, 2016-2023 38
Figure 9: Neurology Devices Market, United States, Company Share (%) 2016 40
Figure 10: CSF Management Market, United States, Revenue Mix ($m), 2016 42
Figure 11: CSF Management Market, United States, Segment Contribution (%), 2016 43
Figure 12: CSF Management Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 44
Figure 13: CSF Management Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Figure 14: CSF Management Market, United States, Volume (Units), Historic, 2009-2016 48
Figure 15: CSF Management Market, United States, Volume (Units), Forecast, 2016-2023 50
Figure 16: CSF Management Market, United States, Company Share (%) 2016 53
Figure 17: Interventional Neurology Market, United States, Revenue Mix ($m), 2016 54
Figure 18: Interventional Neurology Market, United States, Segment Contribution (%), 2016 55
Figure 19: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 56
Figure 20: Interventional Neurology Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 58
Figure 21: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 60
Figure 22: Navigational System Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 62
Figure 23: Embolization and Coiling Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 64
Figure 24: Navigational System Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 66
Figure 25: Interventional Neurology Market, United States, Volume (Units), Historic, 2009-2016 68
Figure 26: Interventional Neurology Market, United States, Volume (Units), Forecast, 2016-2023 70
Figure 27: Embolization and Coiling Devices Market, United States, Volume (Units), Historic, 2009-2016 72
Figure 28: Navigational System Market, United States, Volume (Units), Historic, 2009-2016 74
Figure 29: Embolization and Coiling Devices Market, United States, Volume (Units), Forecast, 2016-2023 76
Figure 30: Navigational System Market, United States, Volume (Units), Forecast, 2016-2023 78
Figure 31: Interventional Neurology Market, United States, Company Share (%) 2016 81
Figure 32: Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2016 83
Figure 33: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2016 84
Figure 34: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 85
Figure 35: Neurological Diagnostic Equipment Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 87
Figure 36: Neurological Diagnostic Equipment Market, United States, Volume (Units), Historic, 2009-2016 89
Figure 37: Neurological Diagnostic Equipment Market, United States, Volume (Units), Forecast, 2016-2023 91
Figure 38: Neurological Diagnostic Equipment Market, United States, Company Share (%) 2016 94
Figure 39: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2016 96
Figure 40: Neurostimulation Devices Market, United States, Segment Contribution (%), 2016 97
Figure 41: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 98
Figure 42: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 100
Figure 43: Neurostimulation Devices Market, United States, Volume (Units), Historic, 2009-2016 102
Figure 44: Neurostimulation Devices Market, United States, Volume (Units), Forecast, 2016-2023 104
Figure 45: Neurostimulation Devices Market, United States, Company Share (%) 2016 107
Figure 46: Neurosurgical Products Market, United States, Revenue Mix ($m), 2016 109
Figure 47: Neurosurgical Products Market, United States, Segment Contribution (%), 2016 110
Figure 48: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 111
Figure 49: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 113
Figure 50: Neurosurgical Products Market, United States, Volume (Units), Historic, 2009-2016 115
Figure 51: Neurosurgical Products Market, United States, Volume (Units), Forecast, 2016-2023 117
Figure 52: Neurosurgical Products Market, United States, Company Share (%) 2016 120
Figure 53: Radiosurgery Market, United States, Revenue Mix ($m), 2016 122
Figure 54: Radiosurgery Market, United States, Segment Contribution (%), 2016 123
Figure 55: Radiosurgery Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 124
Figure 56: Radiosurgery Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 126
Figure 57: Radiosurgery Market, United States, Volume (Units), Historic, 2009-2016 128
Figure 58: Radiosurgery Market, United States, Volume (Units), Forecast, 2016-2023 130
Figure 59: Radiosurgery Market, United States, Company Share (%) 2016 133
Filed in: Medical Device
Publisher : GlobalData